معرفی
Michael Y. Sy, MD, PhD is an Associate Professor in the Department of Neurology at the University of California, Irvine School of Medicine, specializing in multiple sclerosis and autoimmune central nervous system disorders.
Education:
- MD and PhD: UC Irvine College of Medicine
- Residency: Neurology, UC Irvine Medical Center
- Fellowship: Neurology - Multiple Sclerosis, UC Irvine
His research focuses on translational neuroimmunology, investigating biomarkers for disease activity monitoring, safety of B-cell depleting therapies, and glycobiology's role in remyelination. Current work emphasizes precision medicine approaches for multiple sclerosis, NMOSD, and MOGAD through mechanistic studies and clinical trials.
Recent publications (2021-2025) reveal strong trends in serum biomarker validation for hypogammaglobulinemia risk assessment, advanced neuroimaging techniques for demyelinating disorders, and therapeutic applications of N-acetylglucosamine. Key themes include multi-protein assays for disease activity, novel agents like Satralizumab and Frexalimab, and glycobiology mechanisms in myelin repair.
Scientific Awards: No specific awards documented in provided materials.
As Principal Investigator for 7+ clinical trials (including MOGAD studies with Satralizumab and NMOSD registries), Dr. Sy secures industry-sponsored research funding. Patient testimonials consistently highlight his thorough clinical evaluations and exceptional communication skills across UCI Health's Irvine facilities.
He is integral to UCI's Multiple Sclerosis and Neuroimmunology program, collaborating with multidisciplinary teams to advance diagnostics and therapeutics for complex demyelinating conditions while maintaining active clinical practice.
